TY  - BOOK
AU  - Abusnina, Waiel
AU  - Al-Qaraghuli, Abdullah K
AU  - Aladin, Amer
AU  - Banerjee, Avantika
AU  - Ben-Dor, Itsik
AU  - Braun, Ryan
AU  - Case, Brian C
AU  - Chaturvedi, Abhishek
AU  - Chitturi, Kalyan
AU  - Haberman, Dan
AU  - Lupu, Lior
AU  - Merdler, Ilan
AU  - Reddy, Pavan
AU  - Rodriguez-Weisson, Fernando J
AU  - Rogers, Toby
AU  - Satler, Lowell F
AU  - Waksman, Ron
AU  - Wermers, Jason P
TI  - Bioprosthetic Aortic Valve Thrombosis: Definitions, Clinical Impact, and Management: A State-of-the-Art Review. [Review]
SN  - 1941-7640
PY  - 2024///
KW  - *Aortic Valve
KW  - *Bioprosthesis
KW  - *Fibrinolytic Agents
KW  - *Heart Valve Prosthesis
KW  - *Heart Valve Prosthesis Implantation
KW  - *Prosthesis Design
KW  - *Thrombosis
KW  - *Transcatheter Aortic Valve Replacement
KW  - Anticoagulants/ad [Administration & Dosage]
KW  - Anticoagulants/ae [Adverse Effects]
KW  - Anticoagulants/tu [Therapeutic Use]
KW  - Aortic Valve/dg [Diagnostic Imaging]
KW  - Aortic Valve/pp [Physiopathology]
KW  - Aortic Valve/su [Surgery]
KW  - Bioprosthesis/ae [Adverse Effects]
KW  - Fibrinolytic Agents/ad [Administration & Dosage]
KW  - Fibrinolytic Agents/ae [Adverse Effects]
KW  - Heart Valve Prosthesis Implantation/ae [Adverse Effects]
KW  - Heart Valve Prosthesis Implantation/is [Instrumentation]
KW  - Heart Valve Prosthesis/ae [Adverse Effects]
KW  - Humans
KW  - Incidence
KW  - Predictive Value of Tests
KW  - Risk Assessment
KW  - Risk Factors
KW  - Thrombosis/dg [Diagnostic Imaging]
KW  - Thrombosis/et [Etiology]
KW  - Thrombosis/th [Therapy]
KW  - Transcatheter Aortic Valve Replacement/ae [Adverse Effects]
KW  - Transcatheter Aortic Valve Replacement/is [Instrumentation]
KW  - Treatment Outcome
KW  - Automated
KW  - MedStar Heart & Vascular Institute
KW  - MedStar Washington Hospital Center
KW  - Advanced Cardiac Catheterization Research Fellowship
KW  - Interventional Cardiology Fellowship
KW  - Journal Article
KW  - Review
N1  - Available online from MWHC library: 2008 - present
N2  - Bioprosthetic aortic valve thrombosis is frequently detected after transcatheter and surgical aortic valve replacement due to advances in cardiac computed tomography angiography technology and standardized surveillance protocols in low-surgical-risk transcatheter aortic valve replacement trials. However, evidence is limited concerning whether subclinical leaflet thrombosis leads to clinical adverse events or premature structural valve deterioration. Furthermore, there may be net harm in the form of bleeding from aggressive antithrombotic treatment in patients with subclinical leaflet thrombosis. This review will discuss the incidence, mechanisms, diagnosis, and optimal management of bioprosthetic aortic valve thrombosis after transcatheter aortic valve replacement and bioprosthetic surgical aortic valve replacement
UR  - https://dx.doi.org/10.1161/CIRCINTERVENTIONS.123.014143
ER  -